Principia SGR: Principia III Raises 160 Million

Motu Novu’s Client Principia SGR has completed the first closing (equal to 160 million euro) for its new 500-million euro biotech and life sciences fund, Principia III-Health. Moving away from information technology into healthcare technology marks a significant change for Principia SGR, and the opportunity to expand into a thriving global market.